Luke M. Beshar, Director at Protara Therapeutics, Inc. (TARA), bought 10,000 shares at $3.10 ($31K) on 2022-06-30, disclosed to the SEC on 2022-07-05.
Open-market purchase of $31k TARA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| RGNX | SELL | 2018-12-03 | $831K | — | Filing → |
| RGNX | SELL | 2018-11-28 | $2.6M | — | Filing → |
| RGNX | SELL | 2018-11-21 | $3.9M | — | Filing → |